Cagrilintide

Price range: $78.00 through $132.00

CAS #: 1415456-99-3
Molecular Formula: C₁₉₄H₃₁₂N₅₄O₅₉S₂
Molecular Weight (M.W.): Approximately 4409 g/mol
Sequence: Modified peptide analogue; complete structural identity should be verified against lot-specific technical documentation
Product Type: Modified Synthetic Research Peptide

Cagrilintide is a structurally modified synthetic peptide supplied for controlled laboratory and analytical research. Its molecular architecture includes a defined peptide backbone together with additional chemical modifications that distinguish it from a conventional unmodified linear peptide.

Because these structural features contribute directly to the compound’s molecular identity, accurate documentation should include the exact chemical form, salt state, molecular specifications, purity profile, and lot-specific analytical information provided on the applicable Certificate of Analysis.

Research Applications

Cagrilintide may be examined in controlled non-clinical research involving:

  • Modified peptide characterization
  • Ligand-receptor interaction studies
  • Molecular signaling research
  • Structure-function analysis
  • Analytical peptide comparison
  • Stability assessment
  • Non-clinical biochemical and cellular models

Any experimental observations should remain limited to the applicable research system and should not be interpreted as evidence of therapeutic effectiveness, metabolic benefit, weight-related outcomes, or suitability for human use.

Structural Information

Cagrilintide is a modified peptide analogue rather than a simple unmodified amino-acid chain.

Its complete molecular identity may include:

  • A defined peptide backbone
  • Non-standard amino-acid features
  • Lipid-associated structural modification
  • Product-form-specific salt or counter-ion characteristics

These structural elements should be considered when reviewing molecular formula, molecular weight, or sequence-related documentation.

Analytical Identification

Relevant analytical characterization may include:

  • Compound identity confirmation
  • Molecular mass assessment
  • Peptide backbone characterization
  • Modification-site verification
  • Chromatographic purity testing
  • Structural analysis
  • Lot-specific quality testing

Specifications & Documentation

Lot-specific documentation should be reviewed for:

  • Compound identity
  • Molecular formula
  • Molecular weight
  • Peptide structure
  • Structural modifications
  • Salt or counter-ion form
  • Purity specification
  • Analytical testing
  • Lot or batch information
  • Certificate of Analysis
  • Storage requirements

Authenticated product-specific documentation should take precedence over generalized reference values.

Storage & Handling

Store according to the conditions stated on the product label and Certificate of Analysis. Protect the material from environmental conditions that could compromise peptide integrity.

Handling should follow established laboratory procedures appropriate for research materials.

Research Use Only

Cagrilintide is supplied exclusively for laboratory research, analytical testing, and scientific reference purposes.

Disclaimer

For research use only. Not for human or veterinary use. Not intended for consumption, administration, weight-management use, metabolic use, diagnosis, treatment, mitigation, cure, or prevention of any disease. No therapeutic, metabolic, weight-related, medical, or clinical claims are made or implied. Product information is supplied solely for scientific identification, documentation, and research reference.